Pfizer Inc. (NYSE:PFE) announced today that the company will begin shipment of INFLECTRA® (infliximab-dyyb)for injection, a biosimilar of REMICADE®1 (infliximab) to wholesalers in the United States (U.S.) in late November 2016.
Is Inflectra the same as infliximab?
INFLECTRA® is a trademark of Hospira UK, a Pfizer company. INFLECTRA is the first biosimilar to Remicade® (infliximab). Both INFLECTRA and Remicade are infliximab products.
Is infliximab generic?
Remicade generic or biosimilar
Remicade is available only as a brand-name medication. It contains the active drug ingredient infliximab.
Who makes infliximab Remicade?
Remicade is marketed by Janssen Biotech, Inc. (formerly Centocor Biotech, Inc.)
Is Inflectra the same as Remicade?
Remicade (infliximab) and Inflectra (infliximab-dyyb) are biologic medications that treat many autoimmune disorders. Inflectra is highly similar — but not identical — to Remicade. Inflectra doesn't have clinically meaningful differences from Remicade. But it's usually cheaper for most people.
43 related questions foundWhat company makes Inflectra?
Pfizer Inc. (NYSE:PFE) announced today that the company will begin shipment of INFLECTRA® (infliximab-dyyb)for injection, a biosimilar of REMICADE®1 (infliximab) to wholesalers in the United States (U.S.) in late November 2016.
Is Inflectra cheaper than Remicade?
Inflectra, as a biosimilar, is slightly less expensive than Remicade. Inflectra costs about $997 per 100 mg vial while Remicade costs about $1,229 for the same amount.
What pharmaceutical company makes Remicade?
See how our Janssen CarePath Care Coordinators can help you start, stay, and save on REMICADE®.
What is infliximab made from?
Infliximab is made up of human and mouse antibodies. It is an artificial antibody originally developed from mice. Due to human immune reaction to mouse proteins, the mouse common domains are replaced with human antibody domains.
What is the brand name of infliximab?
Infliximab is available under the following different brand names: Remicade, Inflectra, infliximab-dyyb, Renflexis, and infliximab-abda.
Where is Remicade manufactured?
“The various stages of Remicade production occur at Janssen manufacturing sites located in Leiden, The Netherlands, Malvern, Pennsylvania (US), and Schaffhausen, Switzerland,” a spokesperson from the firm told Biopharma-Reporter.com.
Is infliximab an anti CD20 agent?
Around half the patients (48.7%) were switched to another biologic agent. Of those who were switched, the medication they received after infliximab are presented in Table 2. The most common medications received after infliximab were anti-TNF (46.8 %) and anti-CD20 (36.4 %).
What is the generic form of Remicade?
The FDA approved RENFLEXIS as biosimilar to Remicade. This means that RENFLEXIS acts in a similar way to Remicade, and there are no clinically meaningful differences in effectiveness and safety. Your treatment routine stays the same. RENFLEXIS works like Remicade.
What is Inflectra made from?
Infliximab-dyyb, the active ingredient in INFLECTRA, is a chimeric IgG1κ monoclonal antibody (composed of human constant and murine variable regions) specific for human tumor necrosis factor-alpha (TNFα). It has a molecular weight of approximately 149.1 kilodaltons.
What is the difference between Avsola and Remicade?
AVSOLA is a biosimilar to Remicade, an anti-tumor necrosis factor alpha (anti-TNF) monoclonal antibody. The active ingredient of AVSOLA is an anti-TNF monoclonal antibody that has the same amino acid sequence as Remicade. AVSOLA also has the same pharmaceutical dosage form and strength as Remicade.
What is the generic name for Inflectra?
Generic Name: infliximab-dyyb
This medication is used to treat certain types of arthritis (rheumatoid arthritis, arthritis of the spine, psoriatic arthritis), certain bowel diseases (Crohn's disease, ulcerative colitis), and a certain severe skin disease (chronic plaque psoriasis).
How is infliximab manufactured?
Fermentation and harvesting Infliximab is a recombinant antibody produced and secreted from mouse myeloma cells (SP2/0 cells). The antibody is manufactured by continuous perfusion cell culture. Collected harvests are clarified by filtration before further purification.
When was infliximab made?
On August 24, 1998, Remicade® (infliximab), the first tumor necrosis factor-α (TNF) inhibitor, received its initial marketing approval from the US Food and Drug Administration for the treatment of Crohn's disease.
Is infliximab the same as rituximab?
Rituxan (rituximab) and Remicade (infliximab) are monoclonal antibodies used to treat rheumatoid arthritis. Rituxan is also used in combination with other cancer medicines to treat non-Hodgkin's lymphoma.
Who owns Remicade?
Remicade is Johnson & Johnson's bestselling drug and raked in revenues of $1.65 billion in the latest quarter.
How much does Remicade cost without insurance?
A single dose of Remicade can cost from $1,300 to $2,500.
Who makes Remicade in Canada?
Initiative Pushbacks for Ontario
Janssen, the maker of reference infliximab (Remicade), provided the drug free of cost to thousands of patients in Canada over 4 years in what the Globe described as an attempt to discourage official policies favoring lower-cost competitors.
Which is better Remicade or Inflectra?
Conclusions: In the study, it was established that the biosimilar drug (Inflectra®) has a similar efficacy and safety as the reference biological agent (Remicade®), not only in rescue therapy, but also during a 6-month observation period in adult patients with severe UC.
How much does Inflectra cost without insurance?
It is also used to treat ankylosing spondylitis, plaque psoriasis, and some forms of arthritis. The lowest GoodRx price for the most common version of Inflectra is around $3,686.80, 29% off the average retail price of $5,206.11.
Are biosimilars as good as biologics?
Biosimilars are as safe and effective as the original biologic; both are rigorously and thoroughly evaluated by the FDA before approval. Before approving a biosimilar, FDA experts must conclude it is highly similar to and has no clinically meaningful differences from the original biologic.
